Gary Goldberg Planning Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$23K Buy
321
+170
+113% +$12.2K 0.01% 287
2014
Q3
$11K Hold
151
﹤0.01% 368
2014
Q2
$11K Sell
151
-32,884
-100% -$2.38M ﹤0.01% 342
2014
Q1
$2.14M Sell
33,035
-2,827
-8% -$183K 1.05% 29
2013
Q4
$2.13M Sell
35,862
-1,982
-5% -$108K 1.24% 23
2013
Q3
$1.97M Buy
37,844
+3,844
+11% +$193K 1.19% 22
2013
Q2
$1.61M Buy
+34,000
New +$1.73M 1.03% 29

Other funds holding AZN

Gary Goldberg Planning Services's AZN Position: Q4 2014 in Review

Gary Goldberg Planning Services increased its AstraZeneca (AZN) stake by 113% in Q4 2014, buying an estimated $12.2K and bringing the position to 321 shares worth $23K. The position accounts for 0.01% of the portfolio, ranked #287.

Gary Goldberg Planning Services first reported a position in AZN in Q2 2013 and has held it in 7 quarters since. The position peaked at $2.14M in Q1 2014. 403 funds tracked by Wall St. Rank hold AZN as of Q4 2014.

  • Gary Goldberg Planning Services held 321 shares of AstraZeneca worth $23K as of Q4 2014.
  • Gary Goldberg Planning Services bought 170 AstraZeneca shares in Q4 2014, an estimated $12.2K.
  • AstraZeneca made up 0.01% of Gary Goldberg Planning Services's portfolio in Q4 2014, its #287 holding.
  • Gary Goldberg Planning Services first reported a position in AstraZeneca in Q2 2013 and has held it in 7 quarters since.
  • Gary Goldberg Planning Services's AstraZeneca position peaked at $2.14M in Q1 2014.
  • 403 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2014.

Based on Gary Goldberg Planning Services's 13F filing for Q4 2014, filed 9 Feb 2015.